DE60312497D1 - Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika - Google Patents

Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika

Info

Publication number
DE60312497D1
DE60312497D1 DE60312497T DE60312497T DE60312497D1 DE 60312497 D1 DE60312497 D1 DE 60312497D1 DE 60312497 T DE60312497 T DE 60312497T DE 60312497 T DE60312497 T DE 60312497T DE 60312497 D1 DE60312497 D1 DE 60312497D1
Authority
DE
Germany
Prior art keywords
proteins
maba
fabg1
protein
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60312497T
Other languages
English (en)
Other versions
DE60312497T2 (de
Inventor
Annaik Quemard
Gilles Labesse
Mamadou Daffe
Hedia Marrakchi
Dominique Douguet
Martin Cohen-Gonsaud
Stephanie Ducasse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Montpellier I
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Montpellier I
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Montpellier I, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE60312497D1 publication Critical patent/DE60312497D1/de
Application granted granted Critical
Publication of DE60312497T2 publication Critical patent/DE60312497T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
DE60312497T 2002-03-29 2003-03-28 Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika Expired - Lifetime DE60312497T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0204018 2002-03-29
FR0204018A FR2837836B1 (fr) 2002-03-29 2002-03-29 UTILISATION DE LA PROTEINE Maba (FABG1) DE MYCOBACTERIUM TUBERCULOSIS POUR LA CONCEPTION ET LE CRIBLAGE D'ANTIBIOTIQUES
PCT/FR2003/000990 WO2003082911A2 (fr) 2002-03-29 2003-03-28 Utilisation de la proteine maba (fabg1) de mycobacterium tuberculosis pour la conception et le criblage d'antibiotiques

Publications (2)

Publication Number Publication Date
DE60312497D1 true DE60312497D1 (de) 2007-04-26
DE60312497T2 DE60312497T2 (de) 2007-09-20

Family

ID=27839347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60312497T Expired - Lifetime DE60312497T2 (de) 2002-03-29 2003-03-28 Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika

Country Status (8)

Country Link
US (2) US20060035294A1 (de)
EP (1) EP1490491B1 (de)
AT (1) ATE356872T1 (de)
AU (1) AU2003258723A1 (de)
DE (1) DE60312497T2 (de)
ES (1) ES2283790T3 (de)
FR (1) FR2837836B1 (de)
WO (1) WO2003082911A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007107335A1 (en) * 2006-03-23 2007-09-27 Centre National De La Recherche Scientifique Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0707496A4 (de) * 1993-05-13 1997-11-12 Einstein Coll Med METHODEN UND ZUSAMMENSETZUNG ZUR FESTSTELLUNG UND BEHANDLUNG VON MYKOBAKTERIELLEN INFEKTIONEN UNTER VERWENDUNG EINES inhA GENES
AU6949694A (en) * 1993-05-13 1994-12-12 Agresearch Limited Use of genes of m. tuberculosis, m. bovis and m. smegmatis which confer isoniazid resistance

Also Published As

Publication number Publication date
US20100240084A1 (en) 2010-09-23
ATE356872T1 (de) 2007-04-15
ES2283790T3 (es) 2007-11-01
EP1490491B1 (de) 2007-03-14
US20060035294A1 (en) 2006-02-16
FR2837836A1 (fr) 2003-10-03
EP1490491A2 (de) 2004-12-29
WO2003082911A3 (fr) 2004-04-01
AU2003258723A8 (en) 2003-10-13
DE60312497T2 (de) 2007-09-20
WO2003082911A2 (fr) 2003-10-09
AU2003258723A1 (en) 2003-10-13
FR2837836B1 (fr) 2005-04-22

Similar Documents

Publication Publication Date Title
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
ATE478944T1 (de) Zytokin ligand zur behandlung von asthma und atemwegsüberreaktivität
HUP0105331A2 (hu) Új karbonil-reduktáz, ennek génje és alkalmazásának módszere
NZ602351A (en) Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use
ATE293696T1 (de) Mutierte alpha-amylase enzyme mit erhöhter stabilität
NZ596269A (en) Protease screening methods and proteases identified thereby
DE602004031642D1 (de) Methode zur verbesserung der wirksamkeit von biologischen antwort-verändernden proteinen und exemplarische muteine
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
WO2003087138A3 (en) Methods for identifying polypeptide factors interacting with rna
WO2008142664A3 (en) Exposed thymidine kinase 1 peptides, ligands and methods employing the same
PT1276763E (pt) Proteinas anti-congelantes sua producao e utilizacao
ATE211390T1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
DE60312497D1 (de) Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika
WO2008146259A3 (en) Malt1 specific cleavage in assay and screening method
WO2007014951A3 (en) Methods for the screening of antibacterial substances
WO2002062964A3 (en) Ap1 amine oxidase variants
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
DE60121225D1 (de) Tetrapeptidische tryptase substrate und ihre verwendung zur tryptase aktivitätbestimmung
DE50211988D1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren
WO2003073980A3 (en) Recombinant protein c variants
WO2005003289A8 (en) Ap1 amine oxidase variants
WO2006136982A3 (en) An isolated recombinant vaccinia virus complement control protein (hrvcp) polypeptide
SE0003099D0 (sv) Adhesive protein and uses therefore
WO2004048409A3 (en) Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition